John Montalbano - Net Worth and Insider Trading
John Montalbano Net Worth
The estimated net worth of John Montalbano is at least $3 Million dollars as of 2024-09-20. John Montalbano is the Director of Eupraxia Pharmaceuticals Inc and owns about 872,666 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $3 Million. Details can be seen in John Montalbano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Montalbano has not made any transactions after 2021-12-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Montalbano
John Montalbano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Montalbano owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of John Montalbano’s form 4 insider trades.
Insider Ownership Summary of John Montalbano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2021-12-08 | Director |
John Montalbano Latest Holdings Summary
John Montalbano currently owns a total of 1 stock. John Montalbano owns 872,666 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of December 8, 2021, with a value of $3 Million.
Latest Holdings of John Montalbano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2021-12-08 | 872,666 | 3.90 | 3,403,397 |
Holding Weightings of John Montalbano
John Montalbano Form 4 Trading Tracker
According to the SEC Form 4 filings, John Montalbano has made a total of 3 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 10,800 shares on December 8, 2021, which cost John Montalbano around $21,600.
Insider Trading History of John Montalbano
- 1
John Montalbano Trading Performance
GuruFocus tracks the stock performance after each of John Montalbano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Montalbano is -2.49%. GuruFocus also compares John Montalbano's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Montalbano within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Montalbano's insider trading performs compared to the benchmark.
Performance of John Montalbano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.15 | | | | | |
| Relative Return to S&P 500(%) | 6.64 | | | | | |
John Montalbano Ownership Network
John Montalbano Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
John Montalbano is the Director of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Senior Officer Paul Anthony Brennan , and Director or Senior Officer of 10% Security Holder James Besser .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, John Montalbano made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 5,000 shares made by Amanda Michelle Malone , a net purchase of 3,800 shares made by Michael Wilmink , and a net purchase of 6,100 shares made by James Allen Helliwell .
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 24,900 shares were bought by its insiders, resulting in a net purchase of 24,900 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
John Montalbano Mailing Address
Above is the net worth, insider trading, and ownership report for John Montalbano. Currently GuruFocus does not have mailing address information for John Montalbano.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
